Missionirnewsbreaks SS Innovations International, Inc. (NASDAQ: SSII) Announces First Dual-Console, Five-Arm Robotic Beating-Heart Bypass Surgery


Date:

(MENAFN- Investor Brand Network) SS Innovations International (NASDAQ: SSII) announced the successful completion of what it describes as the world's first dual-console, beating-heart totally endoscopic coronary artery bypass (“TECAB”) surgery utilizing all five arms of its SSi Mantra surgical robotic system. The procedure was performed at Medanta – The Medicity Hospital in Gurugram, India, by Dr. Nitin Kumar Rajput of Medanta Hospital and Dr. Lalit Malik of Manipal Hospital, Jaipur, under the guidance of SS Innovations Chairman and CEO Dr. Sudhir Srivastava. The surgeons operated simultaneously using separate control consoles, with all five robotic arms working in synchronization while a stabilization system steadied the surgical area.

The minimally invasive procedure enabled surgeons to perform coronary artery bypass surgery through small incisions without opening the chest or using a heart-lung machine, allowing the patient's heart to continue beating throughout the operation. According to the company, the successful integration of dual-console control and five robotic arms represents an advancement in robotic cardiac surgery. Medanta Hospital Chairman and Managing Director Dr. Naresh Trehan reported that the patient was doing extremely well following the procedure, while SS Innovations highlighted the achievement as part of its mission to make advanced robotic surgery more affordable and accessible worldwide.

To view the full press release, visit

About SS Innovations

SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company's product range includes its proprietary“SSi Mantra” surgical robotic system and its comprehensive suite of“SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company's website at ssinnovations or LinkedIn for more information and updates.

About the SSi Mantra

The SSi Mantra surgical robotic system is a modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the SSi Mantra's standard surgeon command center that is intended to provide equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart is designed to provide the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures.

NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company's newsroom at

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio IBN: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: imer, class="wp-block-paragraph">MissionIR
Austin, Texas

512.354.7000 Office
href="/cdn-cgi/l/email-protection#c98cada0bda6bb8984a0babaa0a6a7809be7aaa6a4" target="_blank" rel="noopener">[email protected]

MissionIR is powered by IBN

MENAFN19112026000224011066ID1111992031


Investor Brand Network

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search